Marco Davila
Senior Vice President and Associate Director for Translational Research · ROSWELL PARK CANCER INSTITUTE
Credentials: · · · · · ·
History
- Present
Lymphoma/ Multiple Myeloma Service Division · ROSWELL PARK CANCER INSTITUTE
- 2008–2010
Medical Oncology
- 2004–2006
2000–2004
Research
Long-Term Follow-up of CD19 CAR Therapy in Acute Lymphoblastic Leukemia
New England Journal of Medicine · 2018 · 2,239 citations
Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia
Science Translational Medicine · 2014 · First of 32 authors · 2,062 citations
Science Translational Medicine · 2013 · 1,696 citations
- FL
39 papers
- MJ
38 papers
- TN
26 papers
- FK
25 papers
- RF
24 papers
- AL
22 papers
18 papers
18 papers
Grants
- 2023–2028
National Heart, Lung, and Blood Institute · R01
PI · $2.8M · Roswell Park Cancer Institute Corp
- 2010–2014
The Adoptive Transfer of Gene-Modified T Cells as a Cell Therapy for Lymphoma
National Cancer Institute · K08
Contact PI · $502K · Sloan-Kettering Inst Can Research